Interleukin-10 Contributes to Therapeutic Effect of Mesenchymal Stem Cells for Acute Liver Failure via Signal Transducer and Activator of Transcription 3 Signaling Pathway
Journal Title: | Chinese Medical Journal 2016, Vol.129 (8), p.967-975 |
Main Author: | Ma, Hu-Cheng |
Other Authors: | Wang, Xin , Wu, Min-Na , Zhao, Xin , Yuan, Xian-Wen , Shi, Xiao-Lei |
Format: |
![]() |
Language: |
English |
Subjects: | |
Publisher: | China: Wolters Kluwer - Medknow Publications |
ID: | ISSN: 0366-6999 |
Link: | https://www.ncbi.nlm.nih.gov/pubmed/27064043 |
Zum Text: |
SendSend as email
Add to Book BagAdd to Book Bag
Staff View

recordid: | cdi_doaj_primary_oai_doaj_org_article_d62cc48aeb5d441dad84ccd2f18781be |
title: | Interleukin-10 Contributes to Therapeutic Effect of Mesenchymal Stem Cells for Acute Liver Failure via Signal Transducer and Activator of Transcription 3 Signaling Pathway |
format: | Article |
creator: |
|
subjects: |
|
ispartof: | Chinese Medical Journal, 2016, Vol.129 (8), p.967-975 |
description: | Background:Mesenchymal stem cells (MSCs) transplantation has been proven to have therapeutic potential for acute liver failure (ALF).However,the mechanism remains controversial.Recently,modulation of inflammation by MSCs has been regarded as a crucial mechanism.The aim of the present study was to explore the soluble cytokines secreted by MSCs and their therapeutic effects in ALF.Methods:MSCs isolated from Sprague-Dawley rats were identified by fluorescence-activated cell sorting analysis.Conditioned medium derived from MSCs (MSCs-CM) was collected and analyzed by a cytokine microarray.MSCs and MSCs-CM were transplanted into rats with D-galactosamine-induced ALF.Liver function,survival rate,histology,and inflammatory factors were determined.Exogenous recombinant rat interleukin (IL)-10,anti-rat IL-10 antibody,and AG490 (signal transducer and activator of transcription 3 [STAT3] signaling pathway inhibitor) were administered to explore the therapeutic mechanism of MSCs-CM.Statistical analysis was performed with SPSS version 19.0,and all data were analyzed by the independent-sample t-test.Results:There are statistical differences of the survival curve between ALF+MSCs group and ALF+Dulbecco's modified Eagle's medium (DMEM) group,as well as ALF+MSCs-CM group and ALF+DMEM group (all P 〈 0.05).Serum alanine aminotransferase (ALT) level in the ALF+MSCs and ALF+MSCs-CM groups was lower than that in the ALF+DMEM group (865.53±52.80 vs.1709.75±372.12 U/L and 964.72±414.59 vs.1709.75±372.12 U/L,respectively,all P 〈 0.05);meanwhile,serum aspartate aminotransferase (AST) level in the ALF+MSCs and ALF+MSCs-CM groups was lower than that in the ALF+DMEM group (2440.83±511.94 vs.4234.35±807.30 U/L and 2739.83±587.33 vs.4234.35±807.30 U/L,respectively,all P 〈 0.05).Furthermore,MSCs or MSCs-CM treatment significantly reduced serum interferon-γ (IFN-γ),IL-1β,IL-6 levels and increased serum IL-10 level compared with DMEM (all P 〈 0.05).Proteome profile analysis of MSCs-CM indicated the presence of anti-inflammatory factors and IL-l 0 was the most distinct.Blocking of IL-10 confirmed the therapeutic significance of this cytokine.Phosphorylated STAT3 was upregulated after IL-l 0 infusion and inhibition of STAT3 by AG490 reversed the therapeutic effect of IL-10.Conclusions:The factors released by MSCs,especially IL-10,have the potential for therapeutic recovery of ALF,and the STAT3 signaling pathway may mediate the anti-inflammatory |
language: | eng |
source: | |
identifier: | ISSN: 0366-6999 |
fulltext: | no_fulltext |
issn: |
|
url: | Link |
@attributes |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PrimoNMBib |
|